FDA Approves Zanvastro for Rare Brain Disorder Alexander Disease

What Is Zanvastro and How Does It Work? The FDA has approved Zanvastro (zilganersen) to treat adults and children with Alexander disease. Alexander disease is a very rare and severe brain disorder that gets worse… Read more

FDA Approves Etcamah Combination for Advanced Breast Cancer

What Is Etcamah, and How Does It Work? The FDA has approved Etcamah (camizestrant) to treat adults with advanced breast cancer. It is used for tumors that are hormone receptor (HR)-positive and human epidermal growth… Read more

FDA Approves Hyrnuo as First Treatment Choice for Specific Type of Lung Cancer

What Is Hyrnuo and How Does It Work? The FDA has granted accelerated approval to Hyrnuo (sevabertinib) for adults with a specific type of advanced lung cancer. It is used for non-squamous non-small-cell lung cancer… Read more

FDA Approves Kerendia for Adults With Type 1 Diabetes and Kidney Disease

What Is Kerendia and How Does It Work? The FDA has approved Kerendia (finerenone) for adults who have chronic kidney disease (CKD) linked to type 1 diabetes. CKD is a condition where the kidneys slowly… Read more

FDA Approves Fayuvi, First Gene Therapy for Children With Sanfilippo Syndrome Type A

What Is Fayuvi and How Does It Work? The FDA has approved Fayuvi (rebisufligene etisparvovec) to treat brain-related symptoms in children with a rare genetic disease called Sanfilippo syndrome type A, also known as mucopolysaccharidosis… Read more

Enhertu Plus Pertuzumab: New First-Line Option for Advanced HER2-Positive Metastatic Breast Cancer

Enhertu (fam-trastuzumab deruxtecan-nxki) is a type of targeted cancer treatment called an antibody-drug conjugate.The FDA has approved it in combination with another medicine, pertuzumab, as the first-line treatment for adults with HER2-positive breast cancer that… Read more